Centino, Ramil S.

HRN: 20-67-44  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/02/2026
CO-AMOXICLAV 625MG (TAB)
04/02/2026
04/09/2026
ORAL
625mg
BID
Soft Tissue Infection
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: